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Abstract
We report a hereditary leukodystrophy in Standard Schnauzer puppies. Clinical signs
occurred shortly after birth or started at an age of under 4 weeks and included apathy,
dysphoric vocalization, hypermetric ataxia, intension tremor, head tilt, circling, propriocep-
tive deficits, seizures and ventral strabismus consistent with a diffuse intracranial lesion.
Magnetic resonance imaging revealed a diffuse white matter disease without mass effect.
Macroscopically, the cerebral white matter showed a gelatinous texture in the centrum semi-
ovale. A mild hydrocephalus internus was noted. Histopathologically, a severe multifocal
reduction of myelin formation and moderate diffuse edema without inflammation was
detected leading to the diagnosis of leukodystrophy. Combined linkage analysis and homo-
zygosity mapping in two related families delineated critical intervals of approximately 29 Mb.
The comparison of whole genome sequence data of one affected Standard Schnauzer to
221 control genomes revealed a single private homozygous protein changing variant in the
critical intervals, TSEN54:c.371G>A or p.(Gly124Asp). TSEN54 encodes the tRNA splicing
endonuclease subunit 54. In humans, several variants in TSEN54 were reported to cause
different types of pontocerebellar hypoplasia. The genotypes at the c.371G>A variant were
perfectly associated with the leukodystrophy phenotype in 12 affected Standard Schnau-
zers and almost 1000 control dogs from different breeds. These results suggest that
TSEN54:c.371G>A causes the leukodystrophy. The identification of a candidate causative
variant enables genetic testing so that the unintentional breeding of affected Standard
Schnauzers can be avoided in the future. Our findings extend the known genotype-pheno-
type correlation for TSEN54 variants.
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Author summary
Various hereditary diseases of the cerebral white matter occur in humans and dogs. We
describe a new leukodystrophy in Standard Schnauzers. Genetic mapping and whole
genome sequence analysis identified a likely candidate causative variant in the TSEN54
gene encoding tRNA splicing endonuclease 54. These results provide new information
about the role of TSEN54 in cell metabolism and the development of the central nervous
system in the late gestational and early post-natal period. The affected dogs potentially
represent a translational large animal model for similar leukoencephalopathies in human
medicine. The clinical phenotype in Schnauzers included multifocal central nervous sys-
tem signs. A holistic pathogenically driven understanding of disease initiation and perpet-
uation requires a solid analysis of the underlying genetics and characterization of the
disease phenotype at the clinical and cellular as well as sub-cellular level. In contrast to the
canine phenotype with a predominant manifestation in the cerebrum white matter, other
TSEN54 variants in humans have been reported to result in a different pathological phe-
notype characterized by pontocerebellar hypoplasia. The differences between humans and
dogs underscore the need for comparative analysis at the clinical, pathological and molec-
ular level to understand species-specific protein mediated pathways, interactions and
outcomes.
Introduction
The term leukoencephalopathy refers to several disorders affecting the white matter of the
central nervous system (CNS) [1,2]. In most cases oligodendrocytes are directly or indirectly
affected by derangement of cellular and molecular pathways causing reduced myelin produc-
tion consisting of diminished quantities, quality or both of this essential component [2].
Depending on the underlying pathology, leukoencephalopathies can be further divided into
two major categories: leukodystrophy and hypomyelination.
In human medicine, hypomyelination, also known as hypomyelinogenesis or dysmyelino-
genesis, is mostly associated with genetic, rarely viral or toxic disorders leading to insufficient
or delayed formation of myelin [3,4]. On the other hand, the term leukodystrophy refers to
progressive disorders of glial cells and myelin maintenance [1,5] resulting in bilateral symmet-
ric lesions in selective areas of the CNS white matter [4]. The diagnosis is accomplished via a
combination of the clinical course of the disease, magnetic resonance imaging (MRI), pathol-
ogy and genetic testing [1,4]. Abnormal formation, turnover and destruction of the myelin are
often caused by a lack of specific enzymes and inborn errors of metabolism [1,4,5].
In veterinary medicine, leukodystrophies were described in many different dog breeds,
such as leukomyeloencephalopathy in Rottweiler [6–8] and Leonberger dogs [9], globoid cell
leukodystrophy or Krabbe’s disease in West Highland White Terriers [10,11] and Australian
Kelpies [12], cavitating leukodystrophy in Dalmatians [13], fibrinoid leukodystrophy or Alex-
ander’s disease in a Labrador Retriever [14] and necrotizing myelopathy in Afghan hounds
[15]. In some of these diseases an autosomal recessive mode of inheritance was described
[11–13]. Causative genetic variants have been identified in GFAP (Labrador Retriever, [14]),
NAPELD (Leonberger Dogs, [9]), and VPS11 (Rottweiler dogs, [8]). The present study aimed
to characterize clinical and pathological features of a new leukodystrophy in Standard Schnau-
zer puppies and to identify its underlying genetic cause.
TSEN54 variant in dogs with leukodystrophy
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Results
Clinical description
A dog breeder reported neurological deficits affecting multiple Standard Schnauzer puppies
over the last ~10 years. Several puppies from different litters involving different dams were
weak and showed progressive neurological signs such as dysphagia, non-ambulatory tetrapar-
esis or sudden death.
For further evaluation of a potential genetic defect in Standard Schnauzers, six puppies (no.
1–4 and 13–14) of two different litters, 4 weeks of age, and one mother of the litters (no. 15)
were presented to the Neurology Service of the Department for Small Animal Medicine and
Surgery, University of Veterinary Medicine Hannover.
Two of the six presented puppies (no. 13 and 14) and the bitch (no. 15) were clinically unre-
markable (S1 Table). The remaining four puppies (no. 1–4) were smaller than the unaffected
siblings (1.0–1.4 kg versus 1.8–2.0 kg). Clinical signs included hypermetric ataxia, circling, dys-
phoria, head tilt (ipsi- or contralateral to direction of circling), bilateral ventro-lateral strabis-
mus and generalized tonic-clonic seizures at the neurological examination. Neuroanatomical
localization in affected puppies indicated diffuse intracranial lesions with a predominance of
forebrain signs.
Basic clinical pathology (differential cell count, liver enzymes, bile acid, bilirubin, urea, cre-
atinine, glucose, total protein, albumin, and electrolytes) of all puppies and cytological exami-
nation of the bitch´s milk were unremarkable.
Magnetic resonance imaging (MRI) of the brain of one affected puppy (no. 1) revealed
mildly enlarged lateral ventricles and a well demarcated bilateral almost symmetrical lesion
affecting the deep and subcortical white matter of the cerebrum diffusely without any mass
effect (Fig 1A–1D). The lesion was markedly hyperintense in T2-weighted (T2w) images
and hypointense in T1-weighted (T1w) and fluid accentuated inversion recovery sequence
(FLAIR). Partial loss of cerebral parenchyma led to a higher content of cerebrospinal fluid
(CSF) within the tissue. No pathological contrast enhancement was visible. MRI of one of
the unaffected Schnauzer puppies (no. 14) was performed to exclude subclinical lesions and
revealed a decreased distinction between white and grey matter (Fig 1E–1H) indicating a
premature myelination which is considered normal at the age of 4 weeks [16]. CSF could not
be obtained. Due to the severe and progressive clinical signs, the four affected puppies were
humanely euthanized.
Necropsy and light microscopy
A total of 12 Standard Schnauzer puppies with neurological disease were examined (no. 1-12).
These included the four clinically investigated puppies (no. 1–4). Relevant pathomorphological
findings during necropsy were restricted to the CNS. The cerebrum of all 12 puppies showed
macroscopically a mild bilateral internal hydrocephalus and the borders between gray and
white matter were indistinct. Additionally, the white matter of the cerebrum had a gelatinous
consistence and showed edema in the 4 week old puppies no. 1–4.
Histologically, a mild (no. 5–12) to severe (no. 1–4), bilateral symmetric multifocal lack of
myelin, mainly in the centrum semiovale was observed using hematoxylin and eosin (HE) and
luxol fast blue and cresyl echt violet (LFB) staining. Additionally, a moderate, diffuse edema
was found in the white matter of the cerebrum of affected animals no. 1–4 (Figs 2–4).
Using β-amyloid precursor protein (APP) specific immunohistochemistry, mild, multifocal
axonal damage was noticed in areas of severe lack of myelin (Fig 4C and 4D). In the combined
TSEN54 variant in dogs with leukodystrophy
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Fig 1. Magnetic resonance imaging (MRI). (A-D) Affected 4 weeks old Schnauzer puppy (no. 1) and (E-H) a
clinically normal sibling at the same age (no. 14). (A, B, E, F) T2 weighted (T2w) sequences; (A, E) transversal and (B,
F) dorsal. (C, D, G, H) T1 weighted (T1w) sequences; (C, G) transversal and (D, H) dorsal. MRI reveals mildly
enlarged and asymmetric lateral ventricles and a T2w-hyperintense/T1w-hypointense lesion diffusely involving the
whole cerebral white matter in affected animals. The age matched unaffected sibling shows beginning myelination in
the central deep white matter, typical for the age.
https://doi.org/10.1371/journal.pgen.1008411.g001
TSEN54 variant in dogs with leukodystrophy
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APP immunohistochemistry and LFB staining the colocalization of axonal damage and myelin
loss was visualized (Fig 4E and 4F).
In addition to the more general histochemical stain for myelin, LFB, two other different
myelin stains were applied, using 20,30-cyclic nucleotide-30-phosphodiesterase (CNPase) as a
marker for early myelin formation and myelin basic protein (MBP) as the prototype of mature
myelin formation.
CNPase immunohistochemistry revealed almost no detectable myelin within the centrum
semiovale and a slightly reduced number of oligodendrocytes in puppies no. 1–4. However, the
Fig 2. Macroscopic overview. (A, B) Age matched healthy control no. 1009. (A) Dorsal view on cerebrum, cerebellum
and brainstem with section plane (white line). (B) Cross section of cerebrum showing the centrum semiovale (red
circle).
https://doi.org/10.1371/journal.pgen.1008411.g002
TSEN54 variant in dogs with leukodystrophy
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cytoplasm of the oligodendrocytes and their fragmented processes were strongly positive (Fig
5A and 5B). Reduced myelination within centrum semiovale was confirmed using an anti-
MBP antibody. Only single, fine strands of myelin were detected in the affected CNS regions
in contrast to the dense meshwork of myelin in unaffected areas of the same animal and in age
matched controls no. 1009–1016 (Fig 5C and 5D).
We quantified mature myelinating oligodendrocytes using an antibody against neurite out-
growth inhibitor A (NogoA). Within the centrum semiovale, affected Schnauzer puppies show
only single NogoA+ oligodendrocytes, whereas age matched healthy control animals show up
to eight times as many myelinating NogoA+ oligodendrocytes as the affected animals in this
area (Fig 6).
Glial fibrillary acidic protein (GFAP)-immunohistochemistry detected a mildly reduced
density of astrocytes within the white matter. Most of these astrocytes had a plump morphol-
ogy and developed shorter and reduced numbers of processes in comparison to the age
matched controls (Fig 7A and 7B). Additionally, using the antibody against ionized calcium
binding adaptor molecule 1 (Iba-1) a higher number of macrophages/microglia within the
affected white matter was detected, whereas an equal distribution of microglia within white
and grey matter was observed in in the age matched controls. The majority of the macro-
phages/microglia within the white matter had an amoeboid morphology (Fig 7C and 7D). Cer-
ebellum, brain stem, spinal cord and peripheral nerves were macroscopically and histologically
unremarkable in the affected dogs.
Genetic analysis
The occurrence of leukodystrophy in multiple consecutive litters from related parents sug-
gested an inherited disease. Pedigree analysis of the four affected puppies no. 1–4 revealed sev-
eral inbreeding loops and was suggestive for a monogenic autosomal recessive inheritance (Fig
8). We obtained genomic DNA samples from the four cases (no. 1–4), five unaffected litter-
mates (no. 13, 14, 19–21) and the four unaffected parents (no. 15–18) of these two litters.
Linkage and autozygosity analysis were performed in the 13 available samples. Eight genomic
segments on six different chromosomes with a total of 29,237,328 bp or roughly 1.2% of the
2.4 Gb dog genome showed linkage in both litters and shared homozygous genotypes in the
four available cases (S2 Table).
Fig 3. Histopathology of the centrum semiovale of the cerebrum. (A) Affected puppy no. 1 and (B) age matched
healthy control no. 1009. (A) Reduced eosinophilia and moderate, diffuse edema of the white matter (asterisk) of
affected puppy. (HE). (B) Regular diffuse eosinophilia, indicating normal myelination, in the white matter of an age
matched control puppy. (HE).
https://doi.org/10.1371/journal.pgen.1008411.g003
TSEN54 variant in dogs with leukodystrophy
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Whole genome sequencing of one of the affected dogs was performed (no. 2). Private
homozygous protein-changing variants were identified by comparing the variants in the
case with the genomes of 8 wolves and 213 dogs from various breeds (Table 1, S3 Table). The
potential leukodystrophy status of control animals was unknown. However, as this is a rare
and severe condition, we assumed the control dogs and wolves to be homozygous for the
genome reference allele at the causative variant.
Fig 4. Histochemistry and immunohistochemistry of the white matter in the centrum semiovale of the cerebrum.
(A, C, E) Affected puppy no. 1 and (B, D, F) age matched healthy control no. 1009. (A) Severe, diffuse lacking bluish
staining, indicating myelin loss and edema in the centrum semiovale (asterisk). Only single fine strands of myelin can
be detected (circle). (LFB). (B) Regularly developed myelin characterized by prominent bluish staining in the white
matter (dark blue). (LFB). (C) Areas of severe myelin loss in the diseased puppies reveal low numbers of damaged
axons (arrows). Vacuolization and loosening of the parenchyma indicate moderate edema. Inset shows a damaged
axon at a higher magnification. (β-amyloid precursor protein, APP). (D) No axonal damage is detectable in healthy
control animals. (APP). (E) Severe, diffuse lacking blue-greenish staining, indicating myelin loss and edema, in the
centrum semiovale, containing low numbers of damaged axons (arrows). Vacuolization and loosening of the
parenchyma represent the moderate edema. Inset shows a damaged axon at a higher magnification. (APP, LFB). (F)
Regularly developed myelin characterized by prominent blue-greenish staining in the white matter (dark teal) without
any damaged axons. (APP, LFB).
https://doi.org/10.1371/journal.pgen.1008411.g004
TSEN54 variant in dogs with leukodystrophy
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Fig 5. Immunohistochemistry of the white matter in the centrum semiovale of the cerebrum. (A, C) Affected puppy
no. 1 and (B, D) age matched healthy control no. 1009. (A) In affected puppies almost no myelin is detectable whereas
oligodendrocytes show fragmented processes and a strongly perinuclear cytoplasmic positive signal (arrows). Inset
shows an oligodendrocyte with strong perinuclear cytoplasmic signal in a higher magnification. (CNPase). (B) In age
matched controls the white matter shows a marked, diffuse brownish staining of the myelin. (CNPase). (C) Only
single, fine strands of myelin (asterisk) were detected in contrast to the dense meshwork of myelin in adjacent non-
affected areas (circle) of diseased puppies. (MBP). (D) Age matched control puppies show a diffuse staining of the
myelin of the white matter (MBP).
https://doi.org/10.1371/journal.pgen.1008411.g005
Fig 6. Immunohistochemistry of the white matter in the centrum semiovale of the cerebrum. (A) Affected puppy no. 1 and (B) age matched
healthy control no. 1009. (A) In affected puppies, only single NogoA+ oligodendrocytes are detectable (arrows). Vacuolization and loosening of the
parenchyma indicate the moderate edema. Inset shows a NogoA+ oligodendrocyte at a higher magnification. (NogoA). (B) Age matched control
animals show numerous NogoA+ myelinating oligodendrocytes. Inset shows NogoA+ oligodendrocytes at a higher magnification. (NogoA). (C)
Statistical analysis of NogoA-immunohistochemstry shows significantly decreased numbers of myelinating oligodendrocytes in the centrum
semiovale of the affected Schnauzer puppies (n = 4, no.1, 2, 3 and 4) in comparison to age matched control animals (n = 4, no. 1009, 1010, 1011
and 1012). Box and whisker plots display median and quartiles with maximum and minimum values. Significant difference (p� 0.05, Mann-
Whitney U-test) is labeled by asterisk.
https://doi.org/10.1371/journal.pgen.1008411.g006
TSEN54 variant in dogs with leukodystrophy
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The variant calling pipeline detected 2.9 million homozygous variants in the genome of the
sequenced case. Of these, 32 were absent from the control genomes and predicted to be pro-
tein-changing. Only one private homozygous protein-changing variant was located in the criti-
cal intervals of combined linkage and autozygosity (Table 1, S4 Table). The variant can be
designated as Chr9:5,015,506C>T (CanFam 3.1 assembly). It was a missense variant affecting
exon 5 of the TSEN54 gene, XM_540434.6:c.371G>A, and predicted to result in a non-conser-
vative exchange of a glycine into an aspartic acid, XP_540434.3:p.(Gly124Asp). The wildtype
glycine is conserved in TSEN54 orthologs across phylogenetically diverse vertebrates (Fig 9).
We genotyped the variant in a larger cohort of 381 Standard Schnauzers (no. 1–381). This
cohort included the four cases from the linkage and autozygosity mapping experiment (no. 1-
4) and an additional eight histopathologically confirmed cases from which only formalin-fixed
material was available (no. 5–12). The genotypes at the TSEN54:c.371G>A variant were per-
fectly associated with the phenotype (PFisher = 6.1 x 10
−22; Table 2). All 12 affected dogs carried
the variant in homozygous state. Among the other 369 Standard Schnauzers, we observed 344
dogs that were homozygous wildtype (93.2%) and 25 dogs that were heterozygous (6.8%) and
presumably carriers for the disease. The sires and dams (no. 15–18) of the four affected dogs
from these two litters were heterozygous (obligate carriers). Most carriers of this variant were
close relatives of the affected Standard Schnauzer puppies. Our cohort included 237 Standard
Fig 7. Immunohistochemistry of the white matter in the centrum semiovale of the cerebrum. (A, C) Affected puppy
no. 1 and (B, D) age matched healthy control no. 1009. (A) There is a reduced density of astrocytes in the white matter
of affected puppies. Most of the astrocytes have a plump morphology developing few short and bulky processes. Inset
shows an astrocyte at a higher magnification. (GFAP). (B) In the white matter of age matched control puppies,
astrocytes have long, slender branching processes. Inset shows an astrocyte at a higher magnification. (GFAP). (C)
Diseased Schnauzer puppies reveal an elevated number of macrophages/microglia in the white matter. Many of these
macrophages/microglia have an amoeboid or reactive morphology (arrows). Inset shows amoeboid macrophages/
microglia at higher magnification. (Iba1). (D) In healthy control dogs, there is an equal distribution of microglia in the
white (W) and the grey (G) matter. Most of the macrophages/microglia represent the ramified, non-reactive type. Inset
shows macrophages/microglia at a higher magnification. (Iba1).
https://doi.org/10.1371/journal.pgen.1008411.g007
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Schnauzers from Finland, which were not specifically collected for this study. In this subset of
dogs, there was only one carrier suggesting that the disease allele may not yet be widespread
globally. We also genotyped 627 dogs from 72 genetically diverse breeds. None of these dogs
carried the mutant allele at the TSEN54:c.371G>A variant (S5 Table).
Fig 8. Pedigree of Standard Schnauzers used for linkage analysis and autozygosity mapping. Filled symbols represent dogs with
leukodystrophy. For a better overview, the pedigree was drawn only with a subset of the closely related dogs. Two litters with a total of four
affected dogs and their parents were used for linkage analysis. The four cases no. 1–4 were used for autozygosity mapping. Numbers indicate
dogs, from which DNA samples were available. The solitary symbols in the square represent 8 additional affected Standard Schnauzers, for
which no pedigree data was available (no. 5–12). For these dogs, only FFPE material was available for DNA isolation. The resulting DNA was of
insufficient quality for genotyping on microarrays, but could be used to determine the genotypes at the TSEN54:c.371G>A variant. The
TSEN54:c.371G>A genotypes for all dogs with DNA samples are indicated in the figure.
https://doi.org/10.1371/journal.pgen.1008411.g008
Table 1. Variants detected by whole genome resequencing of an affected Standard Schnauzer.
Filtering step Variantsa
Homozygous variants in whole genome 2,891,805
Private homozygous variants in the whole genomeb 5,258
Private homozygous protein changing variants in the whole genome 32
Private homozygous protein changing variants in critical intervalsc 1
a All called variants were counted (no quality filter was used).
b Private variants were exclusively called in the affected dog and had homozygous reference or missing genotype calls
in 221 control genomes.
c Intervals of combined linkage and homozygosity (S2 Table)
https://doi.org/10.1371/journal.pgen.1008411.t001
TSEN54 variant in dogs with leukodystrophy
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Fig 9. Details of the TSEN54:c.371G>A variant. (A) Sanger electropherograms from dogs with the three different
genotypes confirm the presence of the variant. (B) A multiple species alignment of the TSEN54 amino acid sequence
illustrates that the variant affects a highly conserved region of the protein. The wildtype glycine is perfectly conserved
across diverse vertebrates. The yeast (S. cerevisiae) SEN54 protein shows overall low amino acid sequence homology
with the vertebrate TSEN54 ortholog. However, the glycine residue is conserved and sits with in a structurally
conserved region consisting of an alpha-helix followed by a beta-sheet.
https://doi.org/10.1371/journal.pgen.1008411.g009
TSEN54 variant in dogs with leukodystrophy
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Immunofluorescence of the cerebrum with an anti-TSEN54 antibody revealed a similar
intra-nucleolar signal in both affected and control animals (no. 1–4 vs. 1009–1016). The distri-
bution and intensity of the signals were equal between cases and controls (Fig 10).
Discussion
In this study, we describe a new inherited leukodystrophy in dogs and identify the TSEN54:c.
Gly124Asp missense variant as a candidate cause of the disease.
The progressive clinical course, the lesions visible in MRI and loss of myelin in the cere-
brum seen light microscopically point towards a demyelinating leukodystrophy rather than
to a hypomyelinating disease. Although there are many different types of leukodystrophy
described in dogs [6–15], the distribution and also the histopathological appearance of the
lesions described in the TSEN54 mutant dogs were different compared to previously described
cases of canine leukodystrophy.
Leukoencephalopathies are a heterogeneous group of diseases affecting the white matter of
the brain. The etiology as well as clinical signs, findings in diagnostic imaging and histopathol-
ogy are highly variable. In most leukoencephalopathies oligodendrocytes and myelin are pre-
dominantly affected, whereas axonal damage represents a rather infrequent finding. However,
axonal damage in areas of myelin lack as shown in the present cases, has been reported as an
epiphenomenon in leukodystrophies [17]. In several leukodystrophic diseases axonal damage
is not directly caused by the lack of myelin or oligodendrocytes and rather represents a second-
ary event [18]. Several possible mechanisms of axonal damage in white matter diseases, such as
sulfatide storage in metachromatic leukodystrophy in humans or aberrant glutamate homeo-
stasis and nitric oxide production in multiple sclerosis have been described [19]. In addition,
an impairment of axons as a consequence of demyelination and the associated loss of myelin-
Table 2. Association of the TSEN54:c.371G>A genotypes with leukodystrophy.
Genotype G/G A/G A/A
Affected Standard Schnauzers (n = 12) - - 12
Standard Schnauzers, population controls (n = 369) 344 25 -
Dogs from other breeds (n = 627)a 627 - -
aThese dogs do not include the 221 control genomes, which were used for the initial analysis. Thus, in total, the
mutant allele was absent from >800 dogs of other breeds.
https://doi.org/10.1371/journal.pgen.1008411.t002
Fig 10. TSEN54 immunofluorescence of the white matter in the centrum semiovale of the cerebrum. (A) Affected
puppy no. 1 and (B) age matched healthy control no. 1009. There is an almost equal number and distribution of cells
showing an intranuclear positive signal for TSEN54 (red). Insets show TSEN54+ cells in a higher magnification.
https://doi.org/10.1371/journal.pgen.1008411.g010
TSEN54 variant in dogs with leukodystrophy
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008411 October 4, 2019 12 / 21
derived trophic support and ion imbalance according to the outside-in model cannot be
excluded [20]. The pathomechanism of axonal damage in TSEN54 associated leukodystrophy
is still unclear and warrants additional investigations.
An inborn lack of central myelination leads to generalized tremor as observed in Springer
Spaniels, Weimaraner dogs or Chow Chows [21–23]. Clinical signs, such as whole body
tremor are present shortly after birth, might remain unchanged or decrease in severity with
time [21–23]. MRI findings in hypomyelination syndromes are rather subtle and include
mildly altered signal intensity of the white matter in comparison to age matched controls and
resembles the myelin pattern of newborn individuals [4].
Destruction of initially normal myelin in the course of the disease is a characteristic feature
of leukodystrophies [2]. The results of the different myelin stains, underline the leukody-
strophic character of the disease of the present cases [24,25]. CNPase immunohistochemistry
detecting both immature oligodendrocytes and early myelin formation showed the presence
of oligodendrocytes and the predominant absence of myelin in the centrum semiovale of the
affected animals. In addition, the MBP immunohistochemistry revealed single fine strands of
mature myelin in affected areas. This could be interpreted as an insufficient and inadequate
myelin formation mediated by the detected genetic defect. Affected puppies are initially nor-
mal and develop progressive neurological signs mostly at 1–6 months of age dependent on the
localization of the lesions. In humans, a systematic analysis of MRI patterns is used to differen-
tiate leukodystrophies from other neurological diseases in children [4]. In veterinary medicine,
MRI findings in leukodystrophies were only described in very few cases so far. Usually marked
T2w hyperintense lesions are visible bilateral symmetrically in the white matter mostly of the
forebrain without any mass effect. Depending on the disease, different distribution patterns of
the lesions were described, affecting mostly the subcortical or the deep cerebral white matter
with or without formation of cavitation [10,26,27]. It is very important to include all available
information concerning macroscopy, histopathologic lesions, anamnesis and also genetics to
come to an appropriate diagnosis.
Several genetic defects have previously been associated with leukodystrophies. In this study,
we identified the TSEN54:c.371G>A missense variant in affected dogs. The variant was identi-
fied during the analysis of two closely related litters with four affected puppies. A combination
of linkage analysis, autozygosity mapping, and whole genome sequencing of one of the cases
identified this variant as the only protein-changing sequence variant that was located in the
critical intervals and private to the sequenced case. The mapping of the disease locus com-
prised several very large genomic intervals comprising more than 29 Mb. Therefore, the results
from the two litters suggested TSEN54:c.371G>A as candidate causative variant with only rela-
tively weak statistical support. During the further course of the research project, DNA from
archived FFPE material of eight additional cases became available for genetic analyses. Consid-
ering that the mutant A-allele is overall relatively rare in Standard Schnauzers, the homozy-
gous mutant A/A genotype in these eight additional cases provides very strong additional
support for a presumed causative role of the TSEN54:c.371G>A missense variant in the phe-
notype. Taken together, all 12 Standard Schnauzers with leukodystrophy were homozygous A/
A, while this genotype was not observed in ~1000 other dogs.
On the other hand, it must be cautioned that the eight additional cases came from the same
breeding lines as the initial four cases and may have been closely related. Thus, while the statis-
tical support for the causality of the TSEN54:c.371G>A missense variant is very strong, it does
not provide definitive proof for the causality. We cannot formally exclude the possibility that
the TSEN54:c.371G>A variant is functionally neutral and in strong linkage disequilibrium to
the true causative variant, which in this case might be e.g. a large structural variant and/or a
non-coding regulatory variant. Large structural variants would have most likely been missed
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by our variant calling pipeline and non-coding regulatory variants would have been filtered
during our prioritization of protein-changing variants.
TSEN54 is a subunit of the tRNA splicing endonuclease complex [28]. Studies in yeast sug-
gest that this complex consists of four subunits (SEN2, SEN34, SEN15 and SEN54) which play
a role in multiple RNA processing events [29]. The exact three-dimensional structure of the
eukaryotic tRNA splicing endonuclease complex has not yet been solved. The large SEN54
subunit is responsible for recognizing the precursor tRNA substrate and positioning the two
catalytical subunits SEN2 and SEN34 to their respective cleavage sites [28]. In line with this
role, yeast SEN54 is a highly basic protein, which facilitates its interaction with the negatively
charged phosphates of the precursor-tRNA. The vertebrate ortholog of yeast SEN54, called
TSEN54, shows relatively little sequence homology, but several structurally conserved motifs
including a predicted alpha-helix followed by a beta-sheet at amino acids 117–131 [29]. The p.
Gly124Asp variant in dogs with leukodystrophy replaces a glycine residue that is conserved
across diverse eukaryotes from yeast to humans with a negatively charged aspartic acid. It is
conceivable that either the spatial requirement of the side chain of the mutant aspartic acid
interferes with the secondary structure of TSEN54 and/or that the additional negative charge
hinders the binding of TSEN54 to the negatively charged precursor tRNA.
TSEN54 has not been directly associated with leukodystrophy before. In humans, high
expression of TSEN54 has been detected in neurons of the pons, cerebellar dentate and olivary
nuclei during the second trimester of pregnancy. A functional endonuclease complex is essen-
tial for the development of these regions [30]. Genetic variants in TSEN54 cause pontocerebel-
lar hypoplasia (PCH) type 2, 4 or 5 in humans [30–32]. PCH is characterized by hypoplasia of
the cerebellum and the ventral pons, early postnatal death and progressive microcephaly and
ventriculomegaly [30–33]. It is histopathologically associated with diffuse gliosis of the white
matter in the brain [34,35]. In one human patient with PCH2, TSEN54:p.Tyr119Glu was iden-
tified as pathogenic variant. This variant is in close proximity to the canine p.Gly124Asp vari-
ant and also introduces an additional negative charge [36].
In zebrafish, knockdown of TSEN54 results in brain hypoplasia and loss of structural defini-
tion in the brain due to increased cell death via loss of functional mechanism [37]. This could
explain the phenotype found in the Standard Schnauzers with mutant TSEN54 described in
our study. Dysfunction and early cell death of oligodendrocytes may lead to dysmyelination
and impaired myelin maintenance which manifests as leukodystrophy. Immunohistochemical
detection of TSEN54 in brains of affected Standard Schnauzers similarly to controls indicated
a functional rather than a quantitative deficiency of TSEN54.
The fact that TSEN54 variants mainly cause pontocerebellar hypoplasia in humans but leu-
kodystrophy in the cerebrum of affected dogs might be explained by a possible distinct quality
or degree of protein malfunction due to the different genetic variants within the gene. Alterna-
tively, TSEN54 might be of minor importance in the neuronal development of dogs compared
to humans and instead be mainly involved in oligodendrocyte function in the canine species
compared to others.
We describe here the first potentially pathogenic TSEN54 variant in dogs. Unlike in
humans, where variants in TSEN54 cause pontocerebellar hypoplasia, the main finding in
affected Standard Schnauzers is leukodystrophy. These findings expand the known genotype-
phenotype correlation for TSEN54 variants.
Conclusions
This study indicates that TSEN54 should be considered as a new candidate gene for leukodys-
trophy. Our findings enable genetic testing for Standard Schnauzers, which can be used to
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avoid the unintentional breeding of affected puppies. This canine leukodystrophy might serve
as a translational large animal model to better understand the function of the TSEN54 protein
and its role in pathophysiology in health and disease.
Materials and methods
Ethics statement
All examinations were performed with written informed owner´s consent according to ethical
guidelines of the University of Veterinary Medicine Hannover, Foundation. Blood samples
were collected with the approval of the Cantonal Committee for Animal Experiments (Canton
of Bern; permit BE75/16). Sample collection in Finland was ethically approved by the Animal
Ethics Committee of State Provincial Office of Southern Finland (ESAVI/343/04.10.07/2016).
All animal experiments were done in accordance with local laws and regulations.
Clinical examinations
A breeder of Standard Schnauzers reported neurological deficits affecting multiple puppies
from approximately ~2014 to ~2017. Several puppies from different litters and bitches were
weak and showed progressive neurological signs such as dysphagia, non-ambulatory tetrapar-
esis or sudden death. For further evaluation of a potential genetic defect in Standard Schnau-
zers, six puppies of two different litters (no. 1–4, 13, 14) were presented to the Neurology
Service of the Department for Small Animal Medicine and Surgery, University of Veterinary
Medicine Hannover. One of the two dams (no. 15) of the affected puppies was also presented
for clinical examination. Clinical examination of the puppies no. 1–4, 13–14 and one mother
(no. 15) was performed by a resident and a Diplomate of the European College of Veterinary
Neurology (ECVN). Details on each individual dog are summarized in the S1 Table.
Magnetic resonance imaging
MRI of puppies no. 1 and 14 were performed in general anesthesia. Puppies were sedated with
diazepam (0.5 mg/kg intravenously (i.v.), Diazepam lipuro, B. Braun Melsungen AG, Melsun-
gen, Germany) and levomethadon (0.2 mg/kg i.v., L-Polamivet, MSD Animal Health GmbH,
Unterschleißheim, Germany). General anesthesia was induced with propofol dosed to effect
(1–3 mg/kg i.v., Narcofol, CP-Pharma, Burgdorf, Germany). Puppies were orotracheally intu-
bated and connected to a semiclosed circle absorber system (Anaesthesia ventilator, Cato,
Dra¨ger, Langenhagen, Germany). Maintenance of anesthesia was performed with isoflurane
(CP-Pharma) in an oxygen/air mixture (1:1, flow 50 ml/kg/min).
The following MRI sequences were obtained with a 3.0-T scanner (Achieva, Philips Medical
Systems, Best, The Netherlands): T2w and T1w pre- and post-contrast administration (0.5 ml/
kg i.v., Dotarem, medithek GmbH, Oststeinbek, Germany) each in sagittal, transversal and
dorsal section as well as transversal section of FLAIR.
Necropsy and histological examination
Four euthanized Standard Schnauzer puppies (no. 1–4) were submitted for complete necropsy.
Additionally, between 2014 and 2017, eight younger Standard Schnauzer puppies from the
same breeder (no. 5–12), 3 to 21 days of age, had been sent to the Department of Pathology,
University of Veterinary Medicine, Hannover, Germany, for post mortem examination. Path-
ological examination was performed according to a routine protocol at the Department of
Pathology, University of Veterinary Medicine, Hannover. During necropsy representative
samples of all organs and tissues were taken and subsequently fixed in 10% neutral buffered
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formalin before being embedded in paraffin wax. For histological examination, 2–3 μm thick
sections were cut and stained with hematoxylin and eosin (HE). Additionally, luxol fast blue-
and cresyl echt violet staining (LFB) was performed to examine myelination and neuronal
degeneration within the central nervous system (CNS).
Immunohistochemistry
Immunohistochemistry was performed on formalin-fixed, paraffin-embedded (FFPE) sections
of cerebrum of affected animals (no. 1–12) and age-matched controls (no. 1009–1016) using
monoclonal antibodies directed against 20,30-cyclic nucleotide-30-phosphodiesterase (CNPase;
MAB 326, dilution 1:100; Chemicon International), β-amyloid precursor protein (β-APP;
MAB 348, dilution 1:800, Chemicon International), and polyclonal antibodies against myelin
basic protein (MBP; AB 980, dilution 1:800, Chemicon International), neurite outgrowth
inhibitor A (NogoA; AB5664, dilution 1:500, Merck Milipore), glial fibrillary acidic protein
(GFAP; Z 0334, dilution 1:200, DAKO) and ionized calcium binding adaptor molecule 1 (Iba-
1; PA5-27436, dilution 1:500, Thermo Fisher Scientific Inc.) to detect oligodendrocytes, axonal
damage, astrocytes, and macrophages/microglia, respectively. Following a described standard
protocol [38] endogenous peroxidase was blocked by a treatment with 0.5% H2O2 diluted in
80% ethanol. Subsequently, sections were heated in a sodium citrate buffer for antigen retrieval
followed by blocking non-specific bindings with 20% goat serum. Thereafter sections were
incubated with the primary antibodies for 90 minutes. Sections for negative control were incu-
bated with non-immune serum. Biotinylated goat-anti-mouse IgG (BA-9200, dilution 1:200,
Vector Laboratories) was used as secondary antibody. To visualize positive antigen-antibody-
reaction, sections were incubated with avidin-biotin-peroxidase complex (ABC, PK-6100,
Vector Laboratories) followed by 3,30-diaminobenzidine tetrahydrochloride (DAB) with
0.03% H2O2, pH 7.2 for 5 minutes and slightly counterstained with Mayer’s hemalaun. For
polyclonal antibodies against Iba-1 the same protocol was used but the secondary antibody
was replaced by biotinylated goat-anti-rabbit IgG (BA-1000, dilution 1:200, Vector Laborato-
ries). For polyclonal antibodies against MBP and GFAP the same protocol was used without
the heating step and using biotinylated goat-anti-rabbit IgG as secondary antibody.
For quantitative analysis of mature oligodendrocytes characterized by NogoA-immunohis-
tochemistry, a morphometric grid (number of positive cell/0,0625mm2) was used.
Combination of immunohistochemistry and histochemistry
A combination of immunohistochemistry and histochemistry, using APP and LFB, was per-
formed as described to point out the localization of damaged axons [38].
Immunofluorescence
Immunofluorescence was performed to visualize the distribution and localization of TSEN54
in the cerebrum according to an established protocol [39]. For this purpose, a monoclonal
mouse anti-human-TSEN54-antibody (anti-TSEN54, sc-398327, dilution 1:50, Santa Cruz
Biotechnology, Inc) was used. Following the same procedure as described above, after dewax-
ing and antigen retrieval, non-specific binding was blocked with 20% goat serum diluted in
diluted in PBS/0.1% Triton X/1% BSA. Thereafter the sections were incubated with the pri-
mary anti-TSEN54 antibody, diluted in PBS/0.1% Triton X/1% BSA. Sections for negative con-
trol were incubated with non-immune serum.
Goat-anti-mouse IgG CyTM3 (115-165-166, dilution 1:200, Jackson ImmunoResearch)
was used as secondary antibody. Nuclear counter-staining was performed with 0.01%
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bisbenzimide (Sigma-Aldrich Chemie GmbH) and sections were mounted with Dako fluores-
cence mounting medium (DakoCytomation GmbH).
Statistical analysis
Statistical analysis of non-normal distributed data generated by NogoA-immunohistochemis-
try was performed by using IBM “Statistic Package for Social Sciences” SPSS program for Win-
dows (version 24) and applying a Mann-Withney U-test for two independent samples. A p-
value of less than or equal to 0.05 was considered statistically significant.
Animal selection for genetic analysis
The genetic study included 381 Standard Schnauzers (S1 Table) from different European
countries and the USA. Twelve closely related dogs presented clinically and/or histopathologi-
cally with leukodystrophy were designated as cases (no. 1–12). The remaining 369 Standard
Schnauzers represented population controls, for which there were no records of neurological
disease. A subset of 237 controls were collected in Finland. This subset was used to estimate
the disease allele frequency in a representative population. Samples from 627 additional dogs
of 72 genetically diverse breeds, which had been donated to the Vetsuisse Biobank, were also
used as controls (S5 Table).
DNA extraction
Genomic DNA was extracted from EDTA blood and hair samples according standard meth-
ods using the Maxwell RSC Whole Blood DNA and the Maxwell RSC Blood DNA Kits in com-
bination with the Maxwell RSC machine (Promega). Genomic DNA from FFPE tissue samples
was extracted using the Maxwell RSC DNA FFPE Kit according manufacturer’s instructions.
Furthermore, a semi-automated DNA extraction robot (PerkinElmer chemagen Technologie
GmbH) was used to extract DNA from the Finnish Standard Schnauzer samples.
Linkage analysis and homozygosity mapping
Linkage analysis and homozygosity mapping with two families were performed (Fig 8). Geno-
type data for 13 members of these two families (no. 1–4, 13–21) were obtained with Illumina
CanineHD BeadChips by Geneseek/Neogen and used for a parametric linkage analysis (S1
File). For all dogs, the call rate was> 95%. Using PLINK v 1.07 [40], markers that were non-
informative, located on the sex chromosomes, or missing in any of the 13 dogs, had Mendel
errors, or a minor allele frequency < 0.05, were removed. The final pruned dataset contained
88,546 markers. To analyze the data for parametric linkage, an autosomal recessive inheritance
model with full penetrance, a disease allele frequency of 0.5 and the Merlin software [41] were
applied.
For homozygosity mapping, the genotype data for the four affected dogs were used. Mark-
ers that were missing in one of the four cases, markers on the sex chromosomes and markers
with Mendel errors in the family were excluded. The—homozyg and—homozyg -group
options in PLINK were used to search for extended regions of homozygosity > 1 Mb. The out-
put intervals were matched against the intervals from linkage analysis in Excel spreadsheets to
find overlapping regions.
Whole genome resequencing and variant filtering
An Illumina TruSeq PCR-free library with an insert size of 400 bp was prepared from one
affected Standard Schnauzer (SM010) and 193 million 2 x 150 bp paired-end reads were
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obtained on an Illumina HiSeq 3000 instrument (21x coverage). Mapping and variant
calling was done as described [42]. The sequence data were deposited under study accession
PRJEB16012 and sample accession SAMEA104500412 at the European Nucleotide Archive.
Functional effects and genomic context of the called variants were annotated using SnpEff soft-
ware [43] together with the NCBI Canis lupus familiaris annotation release 104. For private var-
iant filtering we used control genome sequences from 8 wolves and 213 dogs. These genomes
were either publicly available [44] or produced during other previous projects (S3 Table).
PCR and Sanger sequencing
We used a Sanger sequencing protocol for targeted genotyping of the TSEN54:c.371G>A vari-
ant. Specifically, a 589 bp PCR product was amplified from genomic DNA using the AmpliTaq-
Gold360Mastermix (Life Technologies) or the Biotools DNA Polymerase (Biotools B&M Labs,
S.A.) together with primers 5‘-CGA AGA GGC CTT GTA TCT GC-3‘ (Primer F) and 5’-AAT
TGC CAC CAC TAG GAT GC-3’ (Primer R). For the FFPE samples, a 254 bp PCR product
was amplified from genomic DNA using the AmpliTaqGold360Mastermix (Life Technologies)
together with primers 5’-GCC-TGG-AAG-TTG-CTC-CTT-TA-3’ (Primer FFPE F2) and 5’-
CGG-CAC-CTC-ACT-GGT-ACT-C-3’ (Primer FFPE R2). After treatment with exonuclease
I and alkaline phosphatase, amplicons were sequenced on an ABI 3730 DNA Analyzer (Life
Technologies). Sanger sequences were analyzed with the Sequencher 5.1 software (GeneCodes).
Reference sequences
All analyses were performed using the CanFam 3.1 dog genome assembly as reference
sequence. Numbering within the canine TSEN54 gene refers to NCBI RefSeq accessions
XM_540434.6 (mRNA) and XP_540434.3 (protein) unless explicitly stated otherwise. Num-
bering within the human TSEN54 gene refers to NCBI RefSeq accessions NM_207346.2
(mRNA) and NP_997229.2 (protein).
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